Puma Biotechnology Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Puma Biotech (PBYI) Tops Q2 EPS by 43c
August 8, 2019 4:12 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q2 EPS of ($0.57), $0.43 better than the analyst estimate of ($1.00). Revenue for the quarter came in at $53.9 million versus the consensus estimate of $52.98 million.
The second quarter of 2019 included the achievement of several key milestones for Puma, said Alan H.... More
